Deviation From Model of Normal Aging in Alzheimer’s Disease: Application of Deep Learning to Structural MRI Data and Cognitive Tests

Abstract

Background. Psychophysiological and cognitive tests as well as other functional studies can detect pre-symptomatic stages of dementia. When assembled with structural data, cognitive tests diagnose NDs more reliably thus becoming a multimodal diagnostic tool. Objective. Our main goal is to improve screening for dementia by studying an association between the brain structure and its function. Hypothetically, the brain structure-function association has features specific for either disease-related cognitive deterioration or normal neurocognitive slowing while aging. Materials and methods. We studied a total number of 287 cognitively normal cases, 646 of mild cognitive impairment, and 369 of Alzheimer’s disease. To work out a new marker of neurodegeneration, we created a convolutional neural network-based regression model and predicted the cognitive status of the cognitively preserved examinee from the brain MRI data. This was a model of normal aging. A big deviation from the model suggests a high risk of accelerated cognitive decline. Results. The deviation from the model of normal aging can accurately distinguish cognitively normal subjects from MCI patients (AUC = 0.9957). We also achieved creditable performance in the MCI-versus-AD classification (AUC = 0.9793). We identified a considerable difference in the MMSE test between A-positive and A-negative demented individuals according to ATN-criteria (6.27±1.82 vs 5.32±1.9; $p< 0.05$ ). Conclusion. The deviation from the model of normal aging can be potentially used as a marker of dementia and as a tool for differentiating Alzheimer’s disease from non-Alzheimer’s dementia. To find and justify a reliable threshold levels, further research is required

Keywords

• Error of cognitive score prediction
• biomarker
• Alzheimer’s disease
• neuroimaging
• convolutional neural network
• deep learning